title: The effects of engineered nanoparticles on pulmonary immune homeostasis.
abstract: Engineered nanoparticles (ENP), which could be composed of inorganic metals, metal oxides, metalloids, organic biodegradable and inorganic biocompatible polymers, are being used as carriers for vaccine and drug delivery. There is also increasing interest in their application as delivery agents for the treatment of a variety of lung diseases. Although many studies have shown ENP can be effectively and safely used to enhance the delivery of drugs and vaccines in the periphery, there is concern that some ENP could promote inflammation, with unknown consequences for lung immune homeostasis. In this study, we review research on the effects of ENP on lung immunity, focusing on recent studies using diverse animal models of human lung disease. We summarize how the inflammatory and immune response to ENP is influenced by the diverse biophysical and chemical characteristics of the particles including composition, size and mode of delivery. We further discuss newly described unexpected beneficial properties of ENP administered into the lung, where biocompatible polystyrene or silver nanoparticles can by themselves decrease susceptibility to allergic airways inflammation. Increasing our understanding of the differential effects of diverse types of nanoparticles on pulmonary immune homeostasis, particularly previously underappreciated beneficial outcomes, supports rational ENP translation into novel therapeutics for prevention and/or treatment of inflammatory lung disorders.
authors.affiliation: Department of Immunology and.
authors.forename: Rohimah
authors.initials: R
authors.lastname: Mohamud
authors.forename: Sue D
authors.initials: SD
authors.lastname: Xiang
authors.forename: Cordelia
authors.initials: C
authors.lastname: Selomulya
authors.forename: Jennifer M
authors.initials: JM
authors.lastname: Rolland
authors.forename: Robyn E
authors.initials: RE
authors.lastname: O'Hehir
authors.forename: Charles L
authors.initials: CL
authors.lastname: Hardy
authors.forename: Magdalena
authors.initials: M
authors.lastname: Plebanski
mesh_terms: D056704:Adaptive Immunity / Q000187:drug effects; D000818:Animals; D004337:Drug Carriers / Q000008:administration & dosage / Q000009:adverse effects* / Q000737:chemistry / Q000627:therapeutic use; D006706:Homeostasis / Q000187:drug effects* / Q000276:immunology; D006801:Humans; D007113:Immunity, Innate / Q000187:drug effects; D008168:Lung / Q000187:drug effects / Q000276:immunology; D053758:Nanoparticles / Q000008:administration & dosage / Q000009:adverse effects* / Q000737:chemistry / Q000627:therapeutic use; D010316:Particle Size; D011014:Pneumonia / Q000188:drug therapy / Q000276:immunology* / Q000517:prevention & control; D013499:Surface Properties
chemical_list: D004337:Drug Carriers